Century Therapeutics, Inc.
IPSCBiotechnology
$1.47+0.68%As of Oct 30vs prior close
- Market cap
- $266.2M
- P/E (TTM)
- –
- From 52W high
- −50.00%
- EPS (LTM)
- -$0.14
- Revenue (LTM)
- $109.2M
- Net margin
- -8.78%
- Dividend yield
- 0.00%
Nomior Score
54
Steady ProfileSpeculativeTop 41% of the scored universe
Growth56
Quality54
Value41
Momentum88
Resilience25
Growth
+175.88%revenue a year over 3 fiscal years
YE22 $5.2MLTM $109.2M
Connections
Revenue to profitQ1 YE25
70% of revenue became net profit, up 3352 pts on a year.
Who owns it
2funds